Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The study page still shows a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Study Record page now renders a 403 Forbidden error, blocking access to the study details and related documents.SummaryDifference21%

- Check56 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a small backend/template update with no substantive changes to the study information.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a new page version. The change signals maintenance of the entry but does not alter core content or study details.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page shows a new revision label v3.6.4, replacing v3.6.3. This indicates a small administrative update to the study record without changing core details.SummaryDifference0.0%

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.